AAVantgarde Bio receives FDA fast track designation for AAVB-039 in stargardt disease
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
AINU is set to accelerate its expansion footprint, enhance operational capabilities
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Athena is also exploring the use of this technology for expanded carrier screening
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
Subscribe To Our Newsletter & Stay Updated